{"pmid":32199889,"title":"Should biologics for psoriasis be interrupted in the era of COVID-19?","text":["Should biologics for psoriasis be interrupted in the era of COVID-19?","J Am Acad Dermatol","Lebwohl, Mark","Rivera-Oyola, Ryan","Murrell, Dedee F","32199889"],"journal":"J Am Acad Dermatol","authors":["Lebwohl, Mark","Rivera-Oyola, Ryan","Murrell, Dedee F"],"date":"2020-03-23T11:00:00Z","year":2020,"_id":"32199889","week":"202013|Mar 23 - Mar 29","doi":"10.1016/j.jaad.2020.03.031","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1661985684343226369,"score":6.946335,"similar":[{"pmid":32157783,"title":"COVID-19 and psoriasis: is it time to limit treatment with immunosuppressants? A call for action.","text":["COVID-19 and psoriasis: is it time to limit treatment with immunosuppressants? A call for action.","Dermatol Ther","Conforti, Claudio","Giuffrida, Roberta","Dianzani, Caterina","Di Meo, Nicola","Zalaudek, Iris","32157783"],"journal":"Dermatol Ther","authors":["Conforti, Claudio","Giuffrida, Roberta","Dianzani, Caterina","Di Meo, Nicola","Zalaudek, Iris"],"date":"2020-03-12T11:00:00Z","year":2020,"_id":"32157783","week":"202011|Mar 09 - Mar 15","doi":"10.1111/dth.13298","source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1661359647853903872,"score":40.866142}]}